Acute myelogenous leukemia following complete remission of small cell carcinoma of the lung.

Abstract

The treatment of patients with small cell carcinoma of the lung (SCCL) with combination chemotherapy and radiation has dramatically improved survival in the past decade. With this increased survival, long term complications of therapy are becoming apparent. We report a patient who died of acute myelogenous leukemia (AML) while in complete remission from SCCL. Review of the literature indicates that there may be an increased incidence of AML following successful induction of complete remission in patients with SCCL.

• Authors: P P Yu, J S Waxman, A P Chahinian, A P Efremidis, J F Holland
• Journal: Medical and pediatric oncology (Med Pediatr Oncol) Vol. 14 Issue 2 Pg. 100-3 ( 1986) ISSN: 0098-1532 [Print] United States
• PMID: 3012300 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)

Topics

• Adult
• Aged
• Antineoplastic Combined Chemotherapy Protocols (adverse effects)
• Carcinoma, Small Cell (therapy)
• Female
• Humans
• Leukemia, Myeloid, Acute (etiology)
• Lung Neoplasms (therapy)
• Male
• Middle Aged
• Radiotherapy (adverse effects)